A Study to Investigate the Safety and Tolerability of SCR-6920 Capsule in Patients With Advanced Malignant Tumors

NCT05528055 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

122

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor
Non Hodgkin Lymphoma

Interventions

DRUG: SCR-6920 capsule
DRUG: SCR-6920 capsule
DRUG: SCR-6920 capsule
DRUG: SCR-6920 capsule

Sponsor

Jiangsu Simcere Pharmaceutical Co., Ltd.